Immediate Impact

1 by Nobel laureates 3 from Science/Nature 55 standout
Sub-graph 1 of 23

Citing Papers

Diabetes mellitus—Progress and opportunities in the evolving epidemic
2024 Standout
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
2021 Standout
2 intermediate papers

Works of K. B. JOHANSEN being referenced

Efficacy of metformin in the treatment of NIDDM. Meta-analysis.
1999

Author Peers

Author Last Decade Papers Cites
K. B. JOHANSEN 110 52 23 174 143 18 438
B. A. Skålhegg 137 49 23 84 94 18 481
Marcial Martı́nez 94 123 8 110 68 22 497
Amélie I. S. Sobczak 84 46 12 138 116 12 490
Michael J. Haut 37 88 21 70 30 20 468
Derrick L. Sauls 52 21 17 68 48 19 444
Hendrik J.T. Ruven 102 206 14 154 84 9 436
Philip D. Zieve 25 62 28 116 44 23 413
Ann‐Catrine Teger‐Nilsson 74 109 9 97 23 28 486
Øyvind Hetland 81 126 30 107 24 18 477
Á. Blanco-Molina 95 63 17 57 116 16 393

All Works

Loading papers...

Rankless by CCL
2026